Dr. Ariel Graff is the Head of Multimodal Imaging Group in Schizophrenia and Geriatrics, a Clinician Scientist in the Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health (CAMH), Staff Psychiatrist in the Division of Geriatric Psychiatry at CAMH, Associate Professor of Psychiatry in the Department of Psychiatry at the University of Toronto (UofT). He is also appointed as Medical Head of the inpatient Geriatric Psychiatry Service at CAMH and Full Member in the Institute of Medical Sciences at the UofT.
Areas of Research
The overall aim of Dr. Graff’s research is to better understand the neurobiological characteristics of the different sub-types of schizophrenia as defined by response to treatment. Particularly treatment-resistant schizophrenia and ultra-treatment resistant schizophrenia. Dr. Graff employs a multimodal neuroimaging approach, including positron emission tomography (PET) and magnetic resonance imaging (MRI, fMRI and MRS). PET and MRS allow exploring brain’s neurochemistry in vivo; fMRI explores the neuronal function; and MRI explores the brain structure.
View Dr. Graff's publications on Google Scholar.